Judith Pignac-Kobinger

907 total citations
23 papers, 359 citations indexed

About

Judith Pignac-Kobinger is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Judith Pignac-Kobinger has authored 23 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Judith Pignac-Kobinger's work include Inflammatory Bowel Disease (7 papers), Immune Response and Inflammation (6 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers). Judith Pignac-Kobinger is often cited by papers focused on Inflammatory Bowel Disease (7 papers), Immune Response and Inflammation (6 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers). Judith Pignac-Kobinger collaborates with scholars based in United States, Chile and Spain. Judith Pignac-Kobinger's co-authors include Irina Fernández, Juan F. Burgueño, María T. Abreu, Ana M. Santander, Nivis Brito, Júlia Fritsch, Amar R. Deshpande, Oriana M. Damas, Maria A. Quintero and David H. Kerman and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Gastroenterology.

In The Last Decade

Judith Pignac-Kobinger

22 papers receiving 354 citations

Peers

Judith Pignac-Kobinger
Judith Pignac-Kobinger
Citations per year, relative to Judith Pignac-Kobinger Judith Pignac-Kobinger (= 1×) peers Jaqueline de Azevêdo Silva

Countries citing papers authored by Judith Pignac-Kobinger

Since Specialization
Citations

This map shows the geographic impact of Judith Pignac-Kobinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Pignac-Kobinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Pignac-Kobinger more than expected).

Fields of papers citing papers by Judith Pignac-Kobinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Pignac-Kobinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Pignac-Kobinger. The network helps show where Judith Pignac-Kobinger may publish in the future.

Co-authorship network of co-authors of Judith Pignac-Kobinger

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Pignac-Kobinger. A scholar is included among the top collaborators of Judith Pignac-Kobinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Pignac-Kobinger. Judith Pignac-Kobinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernández, Irina, Maria A. Quintero, Ana M. Santander, et al.. (2022). Lamina Propria Phagocyte Profiling Reveals Targetable Signaling Pathways in Refractory Inflammatory Bowel Disease. SHILAP Revista de lepidopterología. 1(3). 380–392. 6 indexed citations
2.
Mantero, Alejandro, Judith Pignac-Kobinger, Ana M. Santander, et al.. (2022). Combining Pentoxifylline With Vedolizumab for Crohn’s Disease: Results of a Randomised, Placebo-controlled Pilot Study. Journal of Crohn s and Colitis. 16(11). 1687–1695. 1 indexed citations
3.
Abreu, María T., Julie Davies, Maria A. Quintero, et al.. (2022). Transcriptional Behavior of Regulatory T Cells Predicts IBD Patient Responses to Vedolizumab Therapy. Inflammatory Bowel Diseases. 28(12). 1800–1812. 16 indexed citations
4.
Ducasa, Gloria Michelle, Irina Fernández, Nivis Brito, et al.. (2022). EPITHELIAL DUOX2 ACTIVATION INCREASES GUT PERMEABILITY AND BACTERIAL TRANSLOCATION THAT IS RESCUED WITH BUTYRATE SUPPLEMENTATION. Inflammatory Bowel Diseases. 28(Supplement_1). S49–S49. 1 indexed citations
5.
Ducasa, Gloria Michelle, Irina Fernández, Nivis Brito, et al.. (2022). EPITHELIAL DUOX2 ACTIVATION INCREASES GUT PERMEABILITY AND BACTERIAL TRANSLOCATION THAT IS RESCUED WITH BUTYRATE SUPPLEMENTATION. Gastroenterology. 162(3). S49–S49. 1 indexed citations
6.
Fritsch, Júlia, Ana M. Santander, Nivis Brito, et al.. (2021). INFLAMMATORY CYTOKINES AND MICROBIAL LIGANDS AND METABOLITES INTERACT TO MODULATE DUOX2 EXPRESSION AND ACTIVITY. Inflammatory Bowel Diseases. 27(Supplement_1). S26–S27. 1 indexed citations
7.
Burgueño, Juan F., Júlia Fritsch, Ana M. Santander, et al.. (2021). Su115 EPITHELIAL TLR4 INCREASES SUSCEPTIBILITY TO COLITIS-ASSOCIATED CANCER BY PROMOTING MYELOID CELL RECRUITMENT. Gastroenterology. 160(6). S–622.
8.
Mantero, Alejandro, Judith Pignac-Kobinger, Jennifer Rodriguez, et al.. (2021). Fr539 COMBINED EFFECT OF PENTOXIFYLLINE WITH VEDOLIZUMAB IN THE MANAGEMENT OF PATIENTS WITH CROHN'S DISEASE. Gastroenterology. 160(6). S–353. 1 indexed citations
9.
Burgueño, Juan F., Júlia Fritsch, Ana M. Santander, et al.. (2020). Epithelial TLR4 Signaling Activates DUOX2 to Induce Microbiota-Driven Tumorigenesis. Gastroenterology. 160(3). 797–808.e6. 69 indexed citations
10.
Garces, Luis C., Kevin Whelan, David H. Kerman, et al.. (2020). Sa1821 THE FOOD-RELATED QUALITY OF LIFE INSTRUMENT FR-QOL-29 OFFERS A PATIENT-RELEVANT METRIC OF INFLAMMATORY BOWEL DISEASE (IBD) BURDEN AND CAN BE USED IN DIVERSE CULTURAL GROUPS. Gastroenterology. 158(6). S–439. 2 indexed citations
11.
Burgueño, Juan F., Adrian Reich, Maria A. Quintero, et al.. (2020). Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD. Inflammatory Bowel Diseases. 26(6). 797–808. 127 indexed citations
12.
Burgueño, Juan F., Júlia Fritsch, Ana M. Santander, et al.. (2020). P164 EPITHELIAL TLR4-INDUCED DYSBIOSIS INCREASES SUSCEPTIBILITY TO TUMORIGENESIS. Gastroenterology. 158(3). S66–S66. 1 indexed citations
13.
Dheer, Rishu, Julie Davies, Maria A. Quintero, et al.. (2019). Microbial Signatures and Innate Immune Gene Expression in Lamina Propria Phagocytes of Inflammatory Bowel Disease Patients. Cellular and Molecular Gastroenterology and Hepatology. 9(3). 387–402. 25 indexed citations
14.
Burgueño, Juan F., Júlia Fritsch, Ana M. Santander, et al.. (2019). Intestinal Epithelial Cells Respond to Chronic Inflammation and Dysbiosis by Synthesizing H2O2. Frontiers in Physiology. 10. 1484–1484. 35 indexed citations
15.
Burgueño, Juan F., Júlia Fritsch, Yuguang Ban, et al.. (2019). P122 EPITHELIAL TLR4 PROMOTES OXIDATIVE STRESS VIA NADPH OXIDASE ACTIVATION AND INDUCES REDOX-SENSITIVE PATHWAYS DURING TUMORIGENESIS. Gastroenterology. 156(3). S85–S85. 1 indexed citations
16.
Fernández, Irina, Nivis Brito, Juan F. Burgueño, et al.. (2019). P142 CONSTITUTIVELY ACTIVE MAC-1 (CD11B) AMELIORATES INFLAMMATION IN MOUSE DSS COLITIS MODEL. Gastroenterology. 156(3). S95–S95. 1 indexed citations
17.
Burgueño, Juan F., Júlia Fritsch, Yuguang Ban, et al.. (2019). P122 EPITHELIAL TLR4 PROMOTES OXIDATIVE STRESS VIA NADPH OXIDASE ACTIVATION AND INDUCES REDOX-SENSITIVE PATHWAYS DURING TUMORIGENESIS. Inflammatory Bowel Diseases. 25(Supplement_1). S60–S60. 1 indexed citations
18.
Martinez, Laisel, et al.. (2014). Conservation of Pathogenic TCR Homology across Class II Restrictions in Anti-Ribonucleoprotein Autoimmunity: Extended Efficacy of T Cell Vaccine Therapy. The Journal of Immunology. 192(9). 4093–4102. 5 indexed citations
19.
Maldonado, Marcos E., et al.. (2008). Clinical and immunologic manifestations of mixed connective tissue disease in a Miami population compared to a Midwestern US Caucasian population.. PubMed. 35(3). 429–37. 27 indexed citations
20.
Karl, Michael, Mariana Berho, Judith Pignac-Kobinger, Gary E. Striker, & Sharon J. Elliot. (2006). Differential Effects of Continuous and Intermittent 17β-Estradiol Replacement and Tamoxifen Therapy on the Prevention of Glomerulosclerosis. American Journal Of Pathology. 169(2). 351–361. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026